United States · FDA National Drug Code directory

Selegiline Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62135-694_17f2fc17-a150-214b-e063-6294a90ab548
Product NDC: 62135-694
Form: TABLET
Composition / generic term: Selegiline Hydrochloride
Labeler: Chartwell RX, LLC
Marketing category: ANDA
Marketing start / end (source format): 19960802
Source listing expiry: 20261231

Source-listed ingredients

SELEGILINE HYDROCHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

60 TABLET in 1 BOTTLE (62135-694-60) · 62135-694-60

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →